About Us
Dr. Max Group is owned by Penta Investments
Dr. Max Group is fully owned by Penta Investments, an investment group operating Europe, that has been involved in the healthcare industry since 2002, investing in health insurance, hospitals, outpatient clinics, pharmacies and laboratories. Dr. Max streams of business include pharmacies, wholesale and sales and marketing divisions.
Instant development from 2004
Group Management
-
Leonardo Ferrandino
President & CEO of Dr. Max Group
Leonardo Ferrandino
President & CEO of Dr. Max Group
“At Dr. Max Group our long-term strategy is to empower people to work in new ways in order to enhance our customer experience.”
-
Thomas Bornemann
CFO of Dr. Max Group
Thomas Bornemann
CFO of Dr. Max Group
“The Mission of our finance department is to ensure rationale business decisions and enable efficient capital allocation as well as healthy business growth by providing transparency, relevant insights, constructive business partnering and also necessary financial resources.”
-
Ivo Šenkyřík
Head of Group M&A of Dr. Max Group
Ivo Šenkyřík
Head of Group M&A of Dr. Max Group
“We strive to be the market leader in the countries where we operate. The expansion is one of the key pillars how to achieve this long-term goal.”
-
Miguel Martins da Silva
Chief Supply Chain Officer of Dr. Max Group
Miguel Martins da Silva
Chief Supply Chain Officer of Dr. Max Group
“Supply Chain in the Dr.Max Group is about deploying best in class technology and processes and doing things better, in an innovative and efficient way, every day. While we are at this, we never forget that in the end, the customer is the center of all our work and all the decisions we make are therefore focused on how to serve him better.”
-
Luboš Korbelář
Chief Commercial Officer of Dr. Max Group
Luboš Korbelář
Chief Commercial Officer of Dr. Max Group
“Commercial department is part of the DNA of Dr.Max Group. Our work is to split best pieces of DNA and replicate it to other countries.”
-
Dimitrios Tritaris
Chief Marketing & Customer Officer of Dr.Max Group
Dimitrios Tritaris
Chief Marketing & Customer Officer of Dr.Max Group
"The focus on e-comm and digitalisation within the Dr.Max Group is at the forefront, and will strengthen even further in the near future, in order to achieve our challenging goal of being market leader in the countries we operate, and most of all to provide a state of the art digital experience to our loyal customers."
-
Branislav Chmela
Group Retail Operation & HR Officer of Dr. Max Group
Branislav Chmela
Group Retail Operation & HR Officer of Dr. Max Group
-
Jiří Navrátil
Chief Product Officer of Dr. Max Group
Jiří Navrátil
Chief Product Officer of Dr. Max Group
-
Luca Demarchi
Group Chief IT Officer
Luca Demarchi
Group Chief IT Officer
We improve the quality of accessible and affordable care by expanding our assortment of pharmaceutical products and services
To support our vision of becoming a pharmaceutical leader even beyond Central Europe, we do not base our development only on selling pharmaceuticals. With our wide portfolio of private brands, we can offer our clients high-quality products, including affordable medicines. Our distribution centers and first-rate laboratories mean we can provide other services at a very high level as well.
-
We’re Customer Centric. We keep our customer at the heart of everything we do.
-
We’re Ambitious. We strive to be the best.
-
We’re Respectful. We foster culture of empathy and mutual respect.
-
We’re Engaged. We strive consistently for the highest standards.
We’re Customer Centric. We keep our customer at the heart of everything we do.
Every decision, every innovation, and every interaction is driven by a deep understanding of our customers' needs and aspirations.
Our mission is simple: prioritize understanding and anticipate needs, whether for customers, team members, or partners. We exceed expectations through trust, empathy, and exceptional service, ensuring that satisfaction and loyalty are the metrics guiding every decision we make.
We’re Ambitious. We strive to be the best.
We dare to dream big and get inspired by a brave vision to revolutionize the healthcare industry to unlock our full potential, both as individuals and as a company.
We challenge the status quo, innovate, explore new opportunities, and pursue bold goals with determination & accountability. We’re not afraid to set ambitious targets, and pursuing them with passion, creativity, and resilience. Our ambition inspires us to constantly raise the bar and reach excellence in everything we do.
We’re Respectful. We foster culture of empathy and mutual respect.
We value each person’s opinion and personality , showing dignity, kindness, and fairness. Embracing diversity, we celebrate differences, fostering inclusivity, understanding, and collaboration.
Whether colleague, customer, or partner, we honorunique perspectives and contributions, knowing together, we achieve greatness. We actively listen, communicate openly, and respect autonomy, creating a safe, supportive, and inclusive community where all thrive.
We’re Engaged. We strive consistently for the highest standards.
Engagement embodies our commitment to active involvement and dedication. We say what we do and do what we say. We carry our duties with integrity & responsibility, demonstrating enthusiasm and passion.
We foster a culture where every team member contributes meaningfully to our shared success. Through engagement, we demonstrate our dedication to driving positive impact, innovation, and growth.
Dr. Max Group is a European pharmaceutical concern owned by Penta, an investment group established in 1994, operating primarily in the countries of Central and Eastern Europe. Their offices are located in Prague, Bratislava, Warsaw, and Limassol. The business areas of Penta Investments include long-term investing in healthcare, financial services, retail, manufacturing, media and real estate development. The companies of Penta’s portfolio employ more than 43,000 people, with more than 15,000 professionals working in healthcare. The group’s assets value reached €14 billion in 2022.